CDKN2C and T-cell leukemia: Jdp2 is an oncogene that collaborates with the loss of p27kip1 cyclin-dependent inhibitor to induce lymphomas (47) and also negatively regulates Trp53 promoting T-cell leukemia development in mice (42).